Filana Therapeutics Inc FLNA

US Pharmaceuticals

$0.92 ▲ +8.38% (+$0.07)

⬆️ Above Yest. High

Open $0.85

Prev Close $0.85

Day Range $0.83 – $0.94

52W Range $0.67 – $2.27

Market Cap $44.67M

Beta 1.43

EPS (TTM) $-0.88

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-07-14
Shares Out.	48,310,000
Website	cassavasciences.com/ ↗
Phone	13026587581
Employees	20
Revenue	$0
Gross Profit	$0
Net Income	-$8.6M
Free Cash Flow	-$29.3M
Total Assets	$103.9M
Total Liabilities	$40.3M
Equity	$63.6M

About Filana Therapeutics Inc

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Filana Therapeutics Inc is a publicly traded company under the ticker symbol FLNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.